MedTrace Logo

Evaluation of a Device That Separates Blood Cells From Serum/Plasma

NCT02853448 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2023-01-09

No results posted yet for this study

Summary

There are many instances where there is no access to a centrifuge (Emergency wards, EMT truck, battle field, etc.) or when a result is needed immediately (myocardial infarction); a new collection tube which could separate serum and plasma from whole blood immediately upon, if not during, collection, would be extremely beneficial. Such a new tube could save time and cost by eliminating centrifugation steps that are currently required to obtain serum and plasma.

Conditions

  • Plasma Extraction

Interventions

DEVICE

Novel Blood Drawing Apparatus

Sponsors & Collaborators

  • Boston University

    lead OTHER

Principal Investigators

  • Michael F Holick, MD, PhD · Boston University

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2022-06-20
Completion
2022-06-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02853448 on ClinicalTrials.gov